We find the best deals on best-selling Kindle books for you. Just tell us which genres you love and we'll do the rest. The best part? It's completely free!
【姚惠珍/台北報導】國內醫療大廠雃博(4106)今天下午召開記者會宣布,針對全球睡眠呼吸中止醫療器第2大廠澳商ResMed(瑞思邁)先前向美國國際貿易委員會(ITC)控告雃博7項產品侵害專利訴訟一案,雃博已於上周五向美國專利商標局(USPTO)提出多方複查(inter parts review, 簡稱IPR),直搗黃龍、主張ResMed的專利無效,同時將於9月將全新產品搶攻美國市場,搶食全球新台幣1000億元的市場大餅,等同對年營收超過10億美元的ResMed,全面宣戰。
This entry passed through the Full-Text RSS service — if this is your content and you're reading it on someone else's site, please read the FAQ at fivefilters.org/content-only/faq.php#publishers. Five Filters recommends: 'You Say What You Like, Because They Like What You Say' - http://www.medialens.org/index.php/alerts/alert-archive/alerts-2013/731-you-say-what-you-like-because-they-like-what-you-say.html
You are receiving this email because you subscribed to this feed at blogtrottr.com.
留言列表